IMPACT OF THE PEGYLATED-INTERFERON AND RIBAVIRIN THERAPY ON THE TREATMENT-RELATED MORTALITY OF PATIENTS WITH CIRRHOSIS DUE TO HEPATITIS C VIRUS
Author:
Affiliation:
1. Universidade Federal de Ciências da Saúde de Porto Alegre, Brasil
2. Universidade Federal de Ciências da Saúde de Porto Alegre, Brasil; Hospital Nossa Senhora da Conceição, Brasil
3. Hospital Nossa Senhora da Conceição, Brasil
Publisher
FapUNIFESP (SciELO)
Subject
Infectious Diseases,General Medicine
Link
http://www.scielo.br/pdf/rimtsp/v58/0036-4665-rimtsp-58-00037.pdf
Reference41 articles.
1. Treating chronic hepatitis C with peguilated interferon alfa-2a (40 KD) and ribavirin in clinical practice;Lee SS;Aliment Pharmacol Ther,2006
2. Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?;Pascale A;J Hepatol,2013
3. Transection of the oesophagus for bleeding oesophageal varices;Pugh RN;Br J Surg,1973
4. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatites C: a randomised trial;Manns MP;Lancet,2001
5. Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin;Sherman M;Can J Gastroenterol,2006
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Strategies for serum chemokine/cytokine assessment as biomarkers of therapeutic response in HCV patients as a prototype to monitor immunotherapy of infectious diseases;Antiviral Research;2017-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3